108 related articles for article (PubMed ID: 38864249)
1. Exploration of the sensitization effect of Chaihu Shugan powder on chemotherapy for triple-negative breast cancer and its active ingredients.
Wei W; Li X; Li Z
Biopolymers; 2024 Jun; ():e23605. PubMed ID: 38864249
[TBL] [Abstract][Full Text] [Related]
2. Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer.
Fan T; Huang Y; Liu Z; Huang J; Ke B; Rong Y; Qiu H; Zhang B
Drug Des Devel Ther; 2024; 18():1115-1131. PubMed ID: 38618280
[TBL] [Abstract][Full Text] [Related]
3. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
4. Exploring the mechanism by which quercetin re-sensitizes breast cancer to paclitaxel: network pharmacology, molecular docking, and experimental verification.
Yang Y; Yan J; Huang J; Wu X; Yuan Y; Yuan Y; Zhang S; Mo F
Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):3045-3059. PubMed ID: 37148401
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Potential Molecular Mechanism of the Shugan Jieyu Capsule in the Treatment of Depression through Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation.
Liu Z; Huang H; Yu Y; Jia Y; Li L; Shi X; Wang F
Curr Comput Aided Drug Des; 2024; 20(5):501-517. PubMed ID: 37340752
[TBL] [Abstract][Full Text] [Related]
6. Targeting CD73 with flavonoids inhibits cancer stem cells and increases lymphocyte infiltration in a triple-negative breast cancer mouse model.
Mediratta K; El-Sahli S; Marotel M; Awan MZ; Kirkby M; Salkini A; Kurdieh R; Abdisalam S; Shrestha A; Di Censo C; Sulaiman A; McGarry S; Lavoie JR; Liu Z; Lee SH; Li X; Sciumè G; D'Costa VM; Ardolino M; Wang L
Front Immunol; 2024; 15():1366197. PubMed ID: 38601156
[TBL] [Abstract][Full Text] [Related]
7. Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: A network pharmacology study and
Lei S; Zhao S; Huang X; Feng Y; Li Z; Chen L; Huang P; Guan H; Zhang H; Wu Q; Chen B
Front Pharmacol; 2022; 13():967623. PubMed ID: 36172180
[No Abstract] [Full Text] [Related]
8. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective Mechanism and Active Compounds of
Sun X; Zhu Y; Li F; Li M; Wan G
Comput Math Methods Med; 2022; 2022():4338260. PubMed ID: 36213575
[TBL] [Abstract][Full Text] [Related]
10. Network Pharmacology and Experimental Evidence: PI3K/AKT Signaling Pathway is Involved in the Antidepressive Roles of Chaihu Shugan San.
Zhang S; Lu Y; Chen W; Shi W; Zhao Q; Zhao J; Li L
Drug Des Devel Ther; 2021; 15():3425-3441. PubMed ID: 34385814
[TBL] [Abstract][Full Text] [Related]
11. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
[TBL] [Abstract][Full Text] [Related]
12. Exploring the mechanism of action of Yiyi Fuzi Baijiang powder in colorectal cancer based on network pharmacology and molecular docking studies.
Yan H; Li Y; Yang B; Long F; Yang Z; Tang D
Biotechnol Genet Eng Rev; 2023 Feb; ():1-21. PubMed ID: 36735641
[TBL] [Abstract][Full Text] [Related]
13. Integrating GEO, network pharmacology, and in vitro assays to explore the pharmacological mechanism of Bruceae Fructus against laryngeal cancer.
Wu Z; Zhu Z; Fu L
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jun; 397(6):4165-4181. PubMed ID: 38032489
[TBL] [Abstract][Full Text] [Related]
14. Potential active compounds and molecular mechanism of Xuefu Zhuyu decoction for atherosclerosis, based on network pharmacology and molecular docking.
Li Y; Liu B; Liu L; Xu Q; Shen Q; Li W; Zhao J
Medicine (Baltimore); 2022 Aug; 101(32):e29654. PubMed ID: 35960089
[TBL] [Abstract][Full Text] [Related]
15. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
[TBL] [Abstract][Full Text] [Related]
16. Role of corn silk for the treatment of Alzheimer's disease: A mechanism research based on network pharmacology combined with molecular docking and experimental validation.
Tao TZ; Wang L; Liu J
Chem Biol Drug Des; 2023 Nov; 102(5):1231-1247. PubMed ID: 37563784
[TBL] [Abstract][Full Text] [Related]
17. CXCL8 Facilitates the Survival and Paclitaxel-Resistance of Triple-Negative Breast Cancers.
Yi M; Peng C; Xia B; Gan L
Clin Breast Cancer; 2022 Feb; 22(2):e191-e198. PubMed ID: 34284965
[TBL] [Abstract][Full Text] [Related]
18. Molecular Targets and Mechanisms of
Niu K; Li Q; Liu Y; Qiao Y; Li B; Wei C; Wang K; Cui L; Zheng C; Wang R; Zhang L; Zhang H; Sun B; Yu B
Evid Based Complement Alternat Med; 2021; 2021():9929093. PubMed ID: 34149863
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism of Mahuang Lianqiao Chixiaodou Decoction in treating eczema by network pharmacology and molecular docking technology].
Zhang XW; Liu AM; Zhao JJ; Guo J; Chen XY; Qu XX
Zhongguo Zhong Yao Za Zhi; 2021 Feb; 46(4):894-901. PubMed ID: 33645094
[TBL] [Abstract][Full Text] [Related]
20. Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via the AKT/mTOR signaling pathway.
Wu HT; Lin J; Liu YE; Chen HF; Hsu KW; Lin SH; Peng KY; Lin KJ; Hsieh CC; Chen DR
Phytomedicine; 2021 Jan; 81():153437. PubMed ID: 33352494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
